Ningbo Sanxing Medical Electric Co.,Ltd. (SHA:601567)
China flag China · Delayed Price · Currency is CNY
13.37
-0.10 (-0.74%)
Sep 10, 2026, 3:00 PM CST

SHA:601567 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
13,39514,14014,38411,2618,9396,911
Other Revenue
255.42221.02216.26201.71158.82112.31
13,65114,36114,60011,4639,0987,023
Revenue Growth
-12.35%-1.64%27.38%25.99%29.55%-0.98%
Cost of Revenue
10,22510,4489,5847,6006,4875,259
Gross Profit
3,4263,9135,0173,8622,6111,764
Selling, General & Admin
1,9301,9291,9141,6261,188845.78
Research & Development
589.04598.27515.58463.77320.81285.94
Other Operating Expenses
74.38-14.67-71.8819.1123.3640.92
Operating Expenses
2,7162,5892,3822,1341,5221,215
Operating Income
710.261,3232,6351,7291,089548.89
Interest Expense
-135.37-124.49-95-52.75-61.33-83.25
Interest & Investment Income
280.24257.25304.98342.58123.66239.61
Currency Exchange Gain (Loss)
-67.49139.42-111.9440.9255-32.97
Other Non Operating Income (Expenses)
-62.37-33.48-31.01-30.67-17.4542.5
EBT Excluding Unusual Items
725.271,5622,7022,0291,189714.77
Impairment of Goodwill
-355.86-355.86-13.6-8.68-9.49-1.79
Gain (Loss) on Sale of Investments
289.24245.13-177.13132.41-107.48103.7
Gain (Loss) on Sale of Assets
-1.180.6-0.04-0.1-1.88-7.65
Asset Writedown
-11.74-8.01-11.31-1.671.57-4.59
Other Unusual Items
198.52134.83172.96111.4680.7842.38
Pretax Income
844.251,5792,6732,2621,152846.81
Income Tax Expense
263.92330399.32341.26187.04139.2
Earnings From Continuing Operations
580.341,2492,2731,921965.01707.61
Minority Interest in Earnings
9.7525.12-13.72-17.1-16.89-17.57
Net Income
590.081,2742,2601,904948.12690.04
Net Income to Common
590.081,2742,2601,904948.12690.04
Net Income Growth
-74.78%-43.62%18.69%100.79%37.40%-27.83%
Shares Outstanding (Basic)
1,4091,4161,4121,4101,4151,380
Shares Outstanding (Diluted)
1,4091,4161,4121,4101,4151,380
Shares Change
-0.03%0.24%0.14%-0.35%2.54%-0.40%
EPS (Basic)
0.420.901.601.350.670.50
EPS (Diluted)
0.420.901.601.350.670.50
EPS Growth
-74.77%-43.75%18.52%101.49%34.00%-27.54%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
1,241831.91791.631,345818.7-96.3
Free Cash Flow Per Share
0.880.590.560.950.58-0.07
Dividend Per Share
0.1450.6300.8900.6500.3500.320
Dividend Growth
-89.45%-29.21%36.92%85.71%9.38%-8.57%
Gross Margin
25.10%27.25%34.36%33.69%28.70%25.11%
Operating Margin
5.20%9.22%18.05%15.08%11.97%7.82%
Profit Margin
4.32%8.87%15.48%16.61%10.42%9.83%
Free Cash Flow Margin
9.09%5.79%5.42%11.74%9.00%-1.37%
EBITDA
1,0701,6322,9111,9811,317744.1
EBITDA Margin
7.84%11.37%19.94%17.29%14.48%10.60%
D&A For EBITDA
360.22308.97276.45252.77228.7195.22
EBIT
710.261,3232,6351,7291,089548.89
EBIT Margin
5.20%9.22%18.05%15.08%11.97%7.82%
Effective Tax Rate
31.26%20.90%14.94%15.09%16.23%16.44%
Revenue as Reported
13,65114,36114,60011,4639,0987,023
Advertising Expenses
-39.132.2118.0711.288.04